Compound Detail
CHEMBL176045
FANCHININ Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1[C@H](C2)N(C)CC3
Basic Information
| ChEMBL ID | CHEMBL176045 |
| Name | FANCHININ |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WVTKBKWTSCPRNU-KYJUHHDHSA-N |
20
Targets
40
Activities
3
Assay Types
0
PK Parameters
20
Publications
1
Known Names
Molecular Properties
622.8
MW (Da)
7.16
ALogP
8
HBA
0
HBD
61.9
PSA (Ų)
0.24
QED
2
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 33 meas. best 7.53
Ki 5 meas. best 7.14
EC50 2 meas. best 5.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| ECa-109 cell line CHEMBL614668 | IC50 | 7.53 | 7.53 | 29.4 | 2 |
| Muscarinic acetylcholine receptor CHEMBL1907609 | Ki | 7.14 | 7.14 | 73.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 6.59 | 6.565 | 257.0 | 2 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 6.55 | 5.4825 | 284.0 | 4 |
| Small conductance calcium-activated potassium channel protein 2 CHEMBL4469 | Ki | 6.51 | 6.51 | 306.0 | 1 |
| Small conductance calcium-activated potassium channel protein 3 CHEMBL3381 | Ki | 6.34 | 6.34 | 461.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 6.16 | 6.16 | 691.8 | 1 |
| Voltage-gated L-type calcium channel CHEMBL2095177 | Ki | 6.13 | 6.13 | 741.3 | 1 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 5.96 | 5.96 | 1100.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 5.83 | 5.83 | 1480.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.7 | 5.272 | 2000.0 | 5 |
| Unchecked CHEMBL612545 | EC50 | 5.67 | 5.67 | 2150.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 5.23 | 5.165 | 5860.0 | 2 |
| K562 CHEMBL385 | IC50 | 5.19 | 4.9933 | 6430.0 | 3 |
| HepG2 CHEMBL395 | IC50 | 5.17 | 5.17 | 6820.0 | 1 |
| HEL CHEMBL613888 | IC50 | 5.13 | 4.8733 | 7450.0 | 3 |
| MCF7 CHEMBL387 | IC50 | 5.06 | 4.885 | 8620.0 | 2 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.05 | 4.8133 | 8940.0 | 3 |
| Aorta CHEMBL613606 | IC50 | 4.87 | 4.7 | 13489.6 | 2 |
| CCRF-CEM CHEMBL382 | IC50 | 4.8 | 4.8 | 15800.0 | 1 |
| PLC-PRF-5 CHEMBL1075561 | IC50 | 4.73 | 4.73 | 18460.0 | 1 |
| L02 CHEMBL4296457 | IC50 | 4.35 | 4.35 | 44250.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36892076 | 10.1021/acs.jmedchem.2c02061 | ECa-109 cell line | 13 |
| 32942071 | 10.1016/j.ejmech.2020.112810 | Unchecked | 7 |
| 37043739 | 10.1021/acs.jnatprod.3c00159 | Unchecked | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 32503690 | 10.1016/j.bmc.2020.115553 | ATP-dependent translocase ABCB1 | 4 |
| 29624387 | 10.1021/acs.jmedchem.8b00035 | Unchecked | 4 |
| 22766217 | 10.1016/j.bmc.2012.06.017 | U-937 | 4 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| 32942071 | 10.1016/j.ejmech.2020.112810 | HepaRG | 3 |
| 33226219 | 10.1021/acs.jnatprod.0c00946 | A673 | 3 |
| 33226219 | 10.1021/acs.jnatprod.0c00946 | MDA-MB-453 | 3 |
| 33226219 | 10.1021/acs.jnatprod.0c00946 | HCC70 | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 33226219 | 10.1021/acs.jnatprod.0c00946 | HCC1937 | 3 |
| 33226219 | 10.1021/acs.jnatprod.0c00946 | HCC1806 | 3 |
| 33226219 | 10.1021/acs.jnatprod.0c00946 | SJRH30 | 3 |
| 32942071 | 10.1016/j.ejmech.2020.112810 | HepG2 | 3 |
| 33226219 | 10.1021/acs.jnatprod.0c00946 | MDA-MB-231 | 3 |
| 9917283 | 10.1021/np980144f | Plasmodium falciparum | 2 |
| - | 10.6019/CHEMBL4651402 | Vero C1008 | 2 |
Data from ChEMBL 36 via Core Engine